Show simple item record

dc.contributor.authorDeGregori, Jamesen
dc.contributor.authorPharoah, Paulen
dc.contributor.authorSasieni, Peteren
dc.contributor.authorSwanton, Charlesen
dc.date.accessioned2020-12-16T00:30:10Z
dc.date.available2020-12-16T00:30:10Z
dc.date.issued2020-10-12en
dc.identifier.issn1535-6108
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/315140
dc.description.abstractScreening leads to meaningful reductions in deaths from cancers. However, reductions in all-cause mortality (ACM) are harder to demonstrate. Failure to demonstrate ACM benefit should not diminish advances in cancer screening. We consider how co-morbidities related to an aging and damaged soma can hinder achievement of ACM benefit.
dc.languageengen
dc.publisherCell Press
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCancer Screening, Surrogates of Survival, and the Soma.en
dc.typeArticle
prism.endingPage437
prism.issueIdentifier4en
prism.publicationDate2020en
prism.publicationNameCancer Cellen
prism.startingPage433
prism.volume38en
dc.identifier.doi10.17863/CAM.62245
dcterms.dateAccepted2020-09-03en
rioxxterms.versionofrecord10.1016/j.ccell.2020.09.003en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2020-10-12en
dc.contributor.orcidPharoah, Paul [0000-0001-8494-732X]
dc.identifier.eissn1878-3686
rioxxterms.typeJournal Article/Reviewen
cam.issuedOnline2020-09-17en
cam.orpheus.successMon Dec 21 07:30:28 GMT 2020 - Embargo updated*
rioxxterms.freetoread.startdate2021-09-17


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International